Giulia Adriani obtained her PhD in Biomedical and Biomechanical Engineering in 2012. During her PhD she was awarded the Interpolytechnic Doctoral School Fellowship and worked as Research Fellow at The Methodist Hospital Research Institute in Houston, Texas (USA) at the Department of Nanomedicine where she studied the use of nanoparticles as an anticancer drug delivery system. In 2012 she moved to Singapore and joined the National University of Singapore (NUS) and at the Institute of Molecular and Cell Biology (IMCB) to work on semiconductor nanorod used for ultrasensitive biodetection. Since 2013, she has been working at MIT’s research center in Singapore (SMART) in the BioSystems and Micromechanics (BioSyM) Group as Postdoc and Research Scientist on multiple projects in the fields of biomedical engineering, microfluidics and tumour biology. Giulia joined the Singapore Immunology Network (SIgN, A*STAR) in 2019 as Principal Investigator and her main research interest is in 3D microfluidic multicellular systems to study cancer immunotherapy and tumor-immune system interactions.